{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:06:51Z","timestamp":1786975611868,"version":"build-2736575974"},"reference-count":16,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2026,2,1]]},"abstract":"<jats:sec id=\"ab-dbr250013-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Cancer is a life-threatening complication of dermatomyositis (DM) and contributes significantly to mortality. A validated association-based tool is urgently needed to optimize early cancer detection and reduce diagnostic delays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-dbr250013-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To develop and validate a practical prediction model for cancer-associated likelihood in adult patients with DM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-dbr250013-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>A retrospective multicenter cohort study including adults with DM or clinically amyopathic DM was carried out. Participants were recruited from the Department of Dermatology at Ruijin Hospital (training cohort) and the Department of Rheumatology at Renji Hospital (validation cohort) over the period from 2015 to 2022. Multivariate logistic regression and machine learning techniques were employed for model development and validation. The analysis took place in 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-dbr250013-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>DM and clinically amyopathic DM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-dbr250013-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was the occurrence of cancer in patients with DM. Model performance was assessed using the area under the curve to evaluate predictive accuracy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-dbr250013-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 546 adults with DM or clinically amyopathic DM were included, with a mean (SD) age of 49.8 (14.2) years, comprising 166 male individuals (30.4%) and 380 female individuals (69.6%). Five factors significantly associated with concomitant cancers in patients with DM were used to construct the TIP-CA model: anti\u2013transcriptional intermediary factor 1-\u03b3 (TIF1-\u03b3) antibody (positive scored as 1; negative scored as 0), interstitial lung disease (present scored as \u22121; absent scored as 0), poikiloderma (present scored as 1; absent scored as  0), DM subtypes (DM scored as 1; clinically amyopathic DM scored as 0), and anemia (present scored as 1; absent scored as 0). The model demonstrated good discriminatory capability, achieving an area under the curve of 0.809 and 0.808 in the derivation and validation cohorts, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-dbr250013-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>This cohort study found that the TIP-CA model effectively stratified cancer-associated likelihood in patients with DM using routinely available clinical data. By using data from multidisciplinary patient cohorts and incorporating machine learning techniques, the model minimized referral bias. This proposed model may have the potential to guide clinicians in implementing targeted cancer screening strategies and improve patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamadermatol.2025.4824","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T16:00:33Z","timestamp":1764777633000},"page":"176","source":"Crossref","is-referenced-by-count":3,"title":["A Novel Tool for Predicting Malignant Disease in Adult Patients With Dermatomyositis"],"prefix":"10.1001","volume":"162","author":[{"given":"Jiaqi","family":"Ye","sequence":"first","affiliation":[{"name":"Department of Dermatology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanlong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixi","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaile","family":"He","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Teng","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"dbr250013r1","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/1203475416665601","article-title":"Risk of malignancy in dermatomyositis and polymyositis.","volume":"21","author":"Qiang","year":"2017","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"dbr250013r2","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2022.101771","article-title":"Cancer and myositis: Who, when, and how to screen.","volume":"36","author":"Kardes","year":"2022","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"9","key":"dbr250013r3","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/rheumatology\/kew215","article-title":"Temporal relationship between cancer and myositis identifies two distinctive subgroups of cancers: impact on cancer risk and survival in patients with myositis.","volume":"55","author":"Kang","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"dbr250013r4","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103464","article-title":"Clinical features of dermatomyositis patients with anti-TIF1 antibodies: a case based comprehensive review.","volume":"22","author":"Kilinc","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"1","key":"dbr250013r5","doi-asserted-by":"publisher","first-page":"4545","DOI":"10.1038\/s41598-021-83729-5","article-title":"Reappraisal of the incidence, various types and risk factors of malignancies in patients with dermatomyositis and polymyositis in Taiwan.","volume":"11","author":"Hsu","year":"2021","journal-title":"Sci Rep"},{"key":"dbr250013r6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1200804","article-title":"Malignancy in dermatomyositis: a mono-centric retrospective study of 134 patients in China and a potential predictive model.","volume":"10","author":"Tang","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"dbr250013r7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000051611","article-title":"Cutaneous leukocytoclastic vasculitis in dermatomyositis suggests malignancy.","volume":"202","author":"Hunger","year":"2001","journal-title":"Dermatology"},{"issue":"7","key":"dbr250013r8","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1111\/jdv.14759","article-title":"Distinctive cutaneous and systemic features associated with specific antimyositis antibodies in adults with dermatomyositis: a prospective multicentric study of 117 patients.","volume":"32","author":"Best","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"dbr250013r9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/bjd\/ljad396","article-title":"Janus kinase inhibitor for anti-transcription intermediary factor 1-? positive cancer-associated dermatomyositis.","volume":"190","author":"Wu","year":"2024","journal-title":"Br J Dermatol"},{"issue":"7","key":"dbr250013r10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts).","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"issue":"4","key":"dbr250013r11","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1067\/mjd.2002.120621","article-title":"Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sin\u00e9 myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness?","volume":"46","author":"Sontheimer","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"dbr250013r12","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s10067-016-3296-8","article-title":"Malignancy in dermatomyositis and polymyositis: analysis of 192 patients.","volume":"35","author":"Fang","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"34","key":"dbr250013r13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021733","article-title":"Malignancy in dermatomyositis: a retrospective paired case-control study of 202 patients from Central China.","volume":"99","author":"Chang","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"dbr250013r14","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1002\/acr.23188","article-title":"Antinuclear matrix protein 2 autoantibodies and edema, muscle disease, and malignancy risk in dermatomyositis patients.","volume":"69","author":"Albayda","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"dbr250013r15","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.1093\/rheumatology\/kead154","article-title":"Anti-SAE autoantibody in dermatomyositis: original comparative study and review of the literature.","volume":"62","author":"Demortier","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"dbr250013r16","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1093\/rheumatology\/kev247","article-title":"High incidence of cancer in anti-small ubiquitin-like modifier activating enzyme antibody-positive dermatomyositis.","volume":"54","author":"Muro","year":"2015","journal-title":"Rheumatology (Oxford)"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2841811\/jamadermatology_ye_2025_br_250013_1770869617.26374.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:00:26Z","timestamp":1771430426000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2841811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2025.4824","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,1]]}}}